Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,564,038
+$2,981,258 QoQ
Shares Held
85,694
+0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#583
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RESOURCES MANAGEMENT CORP /CT/ /ADV holds $58,736,749 across 9 Drug Manufacturers - General names. ABBV ranks #1 (36.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
85,694 | $21,564,038 | |
| 2 | JNJ |
Johnson & Johnson
|
57,899 | $14,704,609 | |
| 3 | LLY |
ELI LILLY & Co
|
6,910 | $8,288,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
58,507 | $7,518,149 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
20,373 | $2,573,924 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,375 | $1,577,347 | |
| 7 | AMGN |
Amgen Inc
|
3,432 | $1,242,795 | |
| 8 | PFE |
Pfizer Inc
|
39,710 | $956,216 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,564,038 | 85,694 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,582,780 | 85,442 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,285,926 | 84,406 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,603,334 | 84,665 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,853,989 | 85,411 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $17,879,179 | 85,334 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $15,135,775 | 85,176 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,958,358 | 80,810 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $13,954,009 | 81,355 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $14,745,001 | 80,972 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,582,500 | 87,646 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,054,078 | 87,576 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $11,796,554 | 87,557 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $37,386,448 | 234,589 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $14,293,434 | 88,444 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $11,948,850 | 89,031 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $13,540,262 | 88,406 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $14,318,689 | 88,327 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $12,373,799 | 91,387 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $9,713,909 | 90,052 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,134,446 | 89,972 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $9,838,821 | 90,915 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $9,734,577 | 90,850 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,003,273 | 91,372 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,878,908 | 90,435 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $6,810,166 | 89,384 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||